Cargando…

Safety and acceptability of Lactobacillus reuteri DSM 17938 and Bifidobacterium longum subspecies infantis 35624 in Bangladeshi infants: a phase I randomized clinical trial

BACKGROUND: Probiotics have rarely been studied in young healthy infants from low-income countries. This phase I study investigated the safety and acceptability of two probiotics in Bangladesh. METHODS: Healthy infants aged four to twelve weeks from urban slums in Bangladesh were randomized to one o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hoy-Schulz, Yana Emmy, Jannat, Kaniz, Roberts, Thomas, Zaidi, Saira Husain, Unicomb, Leanne, Luby, Stephen, Parsonnet, Julie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4736167/ https://www.ncbi.nlm.nih.gov/pubmed/26832746 http://dx.doi.org/10.1186/s12906-016-1016-1

Ejemplares similares

970 Safety of Bifidobacterium longum infantis and Lactobacillus reuteri in Bangladeshi Infants
por: Hoy-Schulz, Yana Emmy, et al.
Publicado: (2014)

Bifidobacterium longum spp. infantis 35624® en el síndrome de intestino irritable : la ciencia y la evidencia /
por: Valdovinos Díaz, Miguel Angel
Publicado: (2018)

Genome Analysis and Characterisation of the Exopolysaccharide Produced by Bifidobacterium longum subsp. longum 35624(™)
por: Altmann, Friedrich, et al.
Publicado: (2016)

Bifidobacterium longum Subspecies infantis (B. infantis) in Pediatric Nutrition: Current State of Knowledge
por: Chichlowski, Maciej, et al.
Publicado: (2020)

Bifidobacterium infantis 35624 modulates host inflammatory processes beyond the gut
por: Groeger, David, et al.
Publicado: (2013)

Differentiation of Bifidobacterium longum subspecies longum and infantis by quantitative PCR using functional gene targets
por: Lawley, Blair, et al.
Publicado: (2017)

Bifidobacterium longum Subspecies infantis Bacteremia in 3 Extremely Preterm Infants Receiving Probiotics
por: Esaiassen, Eirin, et al.
Publicado: (2016)

Bifidobacterium longum Subspecies infantis Strain EVC001 Decreases Neonatal Murine Necrotizing Enterocolitis
por: Lueschow, Shiloh R., et al.
Publicado: (2022)

Effect of Bifidobacterium longum 35624 on disease severity and quality of life in patients with irritable bowel syndrome
por: Sabaté, Jean-Marc, et al.
Publicado: (2022)

Evaluation of 2’-Fucosyllactose and Bifidobacterium longum Subspecies infantis on Growth, Organ Weights, and Intestinal Development of Piglets
por: Daniels, Victoria C., et al.
Publicado: (2021)

Immunomodulation by Bifidobacterium infantis 35624 in the Murine Lamina Propria Requires Retinoic Acid-Dependent and Independent Mechanisms
por: Konieczna, Patrycja, et al.
Publicado: (2013)

Phylogenomic disentangling of the Bifidobacterium longum subsp. infantis taxon
por: Tarracchini, Chiara, et al.
Publicado: (2021)

Influence of 2′-Fucosyllactose and Bifidobacterium longum Subspecies infantis Supplementation on Cognitive and Structural Brain Development in Young Pigs
por: Sutkus, Loretta T., et al.
Publicado: (2022)

Revisiting the Metabolic Capabilities of Bifidobacterium longum susbp. longum and Bifidobacterium longum subsp. infantis from a Glycoside Hydrolase Perspective
por: Blanco, Guillermo, et al.
Publicado: (2020)

The Effect of Human Milk Oligosaccharides and Bifidobacterium longum subspecies infantis Bi-26 on Simulated Infant Gut Microbiome and Metabolites
por: Salli, Krista, et al.
Publicado: (2023)

Indole-3-lactic acid, a metabolite of tryptophan, secreted by Bifidobacterium longum subspecies infantis is anti-inflammatory in the immature intestine.
por: Meng, Di, et al.
Publicado: (2020)

Bifidobacterium Infantis 35624 Protects Against Salmonella-Induced Reductions in Digestive Enzyme Activity in Mice by Attenuation of the Host Inflammatory Response
por: Symonds, Erin L, et al.
Publicado: (2012)

Evaluation of the Potential of Biofilm Formation of Bifidobacterium longum subsp. infantis and Lactobacillus reuteri as Competitive Biocontrol Agents Against Pathogenic and Food Spoilage Bacteria
por: Speranza, Barbara, et al.
Publicado: (2020)

Effects of Probiotic (Bifidobacterium longum 35624) Supplementation on Exercise Performance, Immune Modulation, and Cognitive Outlook in Division I Female Swimmers
por: Carbuhn, Aaron F., et al.
Publicado: (2018)

Lactobacillus Reuteri DSM 17938 (Limosilactobacillus reuteri) in Diarrhea and Constipation: Two Sides of the Same Coin?
por: Saviano, Angela, et al.
Publicado: (2021)

Lactobacillus reuteri DSM 17938 Improves Feeding Intolerance in Preterm Infants
por: Kaban, Risma K., et al.
Publicado: (2019)

Persistence of Supplemented Bifidobacterium longum subsp. infantis EVC001 in Breastfed Infants
por: Frese, Steven A., et al.
Publicado: (2017)

Safety and tolerability of Bifidobacterium longum subspecies infantis EVC001 supplementation in healthy term breastfed infants: a phase I clinical trial
por: Smilowitz, Jennifer T., et al.
Publicado: (2017)

Potential Applications of Endo-β-N-Acetylglucosaminidases From Bifidobacterium longum Subspecies infantis in Designing Value-Added, Next-Generation Infant Formulas
por: Duman, Hatice, et al.
Publicado: (2021)

Detection and Physicochemical Characterization of Membrane Vesicles (MVs) of Lactobacillus reuteri DSM 17938
por: Grande, Rossella, et al.
Publicado: (2017)

Erratum to: Safety and tolerability of Bifidobacterium longum subspecies infantis EVC001 supplementation in healthy term breastfed infants: a phase I clinical trial
por: Smilowitz, Jennifer T., et al.
Publicado: (2017)

Mining Milk for Factors which Increase the Adherence of Bifidobacterium longum subsp. infantis to Intestinal Cells
por: Quinn, Erinn M., et al.
Publicado: (2018)

Supplementation with Bifidobacterium longum subspecies infantis EVC001 for mitigation of type 1 diabetes autoimmunity: the GPPAD-SINT1A randomised controlled trial protocol
por: Ziegler, Anette-Gabriele, et al.
Publicado: (2021)

The efficacy of Lactobacillus reuteri DSM 17938 in infants and children: a review of the current evidence
por: Urbańska, Magdalena, et al.
Publicado: (2014)

Human Skin Bacterial Community Response to Probiotic (Lactobacillus reuteri DSM 17938) Introduction
por: Frerejacques, Marie, et al.
Publicado: (2020)

Dietary supplementation with Bifidobacterium longum subsp. infantis (B. infantis) in healthy breastfed infants: study protocol for a randomised controlled trial
por: Awasthi, Smita, et al.
Publicado: (2016)

Snack food consumption among Bangladeshi children, supplementary data from a large RCT
por: Jannat, Kaniz, et al.
Publicado: (2020)

Oligosaccharide Binding Proteins from Bifidobacterium longum subsp. infantis Reveal a Preference for Host Glycans
por: Garrido, Daniel, et al.
Publicado: (2011)

Proteomic Analysis of Bifidobacterium longum subsp. infantis Reveals the Metabolic Insight on Consumption of Prebiotics and Host Glycans
por: Kim, Jae-Han, et al.
Publicado: (2013)

Bifidobacterium longum subsp. infantis in experimental necrotizing enterocolitis: alterations in inflammation, innate immune response, and the microbiota
por: Underwood, Mark A., et al.
Publicado: (2014)

Reduced colonic mucin degradation in breastfed infants colonized by Bifidobacterium longum subsp. infantis EVC001
por: Karav, Sercan, et al.
Publicado: (2018)

Draft Genome Sequence of Bifidobacterium longum subsp. infantis BI-G201, a Commercialization Strain
por: Song, Jinan, et al.
Publicado: (2020)

Milk phospholipids protect Bifidobacterium longum subsp. infantis during in vitro digestion and enhance polysaccharide production
por: Kosmerl, Erica, et al.
Publicado: (2023)

Efficacy of Lactobacillus reuteri DSM 17938 for infantile colic: Systematic review with network meta-analysis
por: Gutiérrez-Castrellón, Pedro, et al.
Publicado: (2017)

Impact of the fermentation parameters pH and temperature on stress resilience of Lactobacillus reuteri DSM 17938
por: Hernández, Armando, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_2c3nlqt4026k9chesqr4hirpdd